ARCHIVES

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 10 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Letter: No Intent To Link Flags With NSABP Inquiry, ORI’s Bivens Writes

March 10, 1995

Standard Surgical Protocol Improved Endometrial Staging

October 27, 2006

Solomon Garb’s Questions/Answers

January 9, 1981

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

March 26, 2010

Tobacco Interests Contribute a Portion Of the $109 Million Raised by Stand Up To Cancer

September 12, 2014

NCAB Ponders Patient Accrual Problems, Members Irate Over System That Discourages Participation

February 19, 1988